Feedback / Questions
Bimzelx (bimekizumab) - UCB
Abrilada (adalimumab-afzb) - Pfizer
izokibep (ABY-035) - Affibody, ACELYRIN
https://www.medpagetoday.com/meetingcoverage/aad/103606
Mar 20, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next